Company Overview and News
Metro Mining Ltd (ASX:MMI) managing director & CEO Simon Finnis speaks with Proactive Investors about the bauxite producer’s Bauxite Hills Mine in northern Queensland, which began production in April.
Metro Mining Ltd (ASX:MMI) has shipped one million tonnes of bauxite since beginning operations at its Bauxite Hills Mine north of Weipa in Far North Queensland on April 13, 2018.
Metro Mining Ltd (ASX:MMI) was recognised in August 2018 as Australia’s leading emerging mining company at the globally renown Diggers & Dealers resources conference in Kalgoorlie.
Metro Mining Ltd (ASX:MMI) has signed a new binding contract with China’s state-owned State Power Investment Corporation Aluminium and Electric Power Investment Co. Ltd (SPIC).
Metro Mining Ltd (ASX:MMI) has secured further bauxite offtake agreements with Chinese partners for 2018/2019 production from its Bauxite Hills operation in Far North Queensland.
Metro Mining Ltd (ASX:MMI) has been recognised for getting the Bauxite Hills project in Far North Queensland operational by being named Australia’s leading emerging mining company.
Diggers and Dealers Mining Forum will attract some higher profile Australian mining companies to Kalgoorlie-Boulder next week, with the forum’s chairman tipping a ‘buoyant’ Diggers with great presentations.
NCMGF PILBF NCM RMS GCY EVN SCEXF SNDFY NST DCN IGO AGY ARYMF RSG MMI RMGGF SFR SBM CAHPF FMG WNARF WSA PLS IIDDY FSUGY NESRF NCMGY FSUMF SFRRF RMGGY NHRNY PEX RMLRF SAR
Metro Mining Ltd (ASX:MMI) director Dongping Wang has retired from the company’s board after eight years of service with Xiaoming Yuan appointed in his place.
Metro Mining Ltd’s (ASX:MMI) Bauxite Hills Mine in Queensland has experienced a steady ramp-up during the quarter and is now approaching the budgeted operating rates and achieving very consistent results on a daily basis.
Metro Mining Ltd (ASX:MMI) has had Renaissance Smaller Companies Pty Ltd lodge its notice of initial substantial shareholder after accumulating a 5.34% holding in the company.
TORONTO, June 22, 2018 (GLOBE NEWSWIRE) -- Melior Resources Inc. (TSXV:MLR) (“Melior” or the “Company”) today announced that Mr. George Lloyd would be joining the board as an independent non-executive director.
MMI CCJMF ILKAF CCJMD ILKAY MLR ILU
Metro Mining’s equity raising effort has led to an oversubscribed institutional placement, exceeding its initial equity raising ambitions of $15 million up to a total of $17.5 million.
Metro Mining Ltd (ASX:MMI) has successfully completed a bookbuild to raise $17.5 million via an institutional placement, at an issue price of 20 cents per share.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to ASX:MMI / METRO MINING LIMITED on message board site Silicon Investor.